معرفی
Robert M. Swift is a Professor of Psychiatry and Human Behavior and Professor of Behavioral and Social Sciences at Brown University. He holds roles as Associate Chief of Staff for Mental Health and Acting Associate Chief of Staff for Education at the Providence VA Medical Center. Dr. Swift earned dual B.A., M.D., and Ph.D. degrees from the University of Chicago, followed by a psychiatry residency at Yale University. Board-certified in Adult Psychiatry and Addiction Psychiatry, his research focuses on pharmacological treatments for alcohol and drug dependence, with emphasis on clinical trials and mechanistic studies of medications like naltrexone, topiramate, and novel agents such as GET 73. He has led major NIH-funded studies including the COMBINE trial evaluating combined psychotherapy and pharmacotherapy for alcohol dependence.
- Education: B.A., Ph.D., and M.D. from University of Chicago
- Residency: Yale University Department of Psychiatry
His research interests span pharmacotherapy mechanisms, genetic influences on addiction, and real-time alcohol monitoring technologies. Key areas include alpha-adrenergic modulation (prazosin/doxazosin), ghrelin’s role in craving, and transdermal alcohol sensors. Dr. Swift has authored over 125 peer-reviewed articles and serves on review committees for NIH and industry, including the prestigious Neural Basis of Psychopathology grant panel (2011–2014).
Notable grants include the NIAAA-funded cooperative study on quetiapine and a VA trial on prazosin for PTSD. His awards include Distinguished Fellow status from APA and leadership roles in the Research Society on Alcoholism. Collaborations span departments at Brown, VA, and international institutions.
